BR112015022747A2 - materiais de prevenção de obstrução gastrointestinal - Google Patents

materiais de prevenção de obstrução gastrointestinal

Info

Publication number
BR112015022747A2
BR112015022747A2 BR112015022747A BR112015022747A BR112015022747A2 BR 112015022747 A2 BR112015022747 A2 BR 112015022747A2 BR 112015022747 A BR112015022747 A BR 112015022747A BR 112015022747 A BR112015022747 A BR 112015022747A BR 112015022747 A2 BR112015022747 A2 BR 112015022747A2
Authority
BR
Brazil
Prior art keywords
gastrointestinal obstruction
materials
prevention materials
obstruction prevention
peptide
Prior art date
Application number
BR112015022747A
Other languages
English (en)
Other versions
BR112015022747B1 (pt
BR112015022747A8 (pt
Inventor
Yahagi Naohisa
Kobayashi Satoru
Uraoka Toshio
Original Assignee
3 D Matrix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3 D Matrix Ltd filed Critical 3 D Matrix Ltd
Publication of BR112015022747A2 publication Critical patent/BR112015022747A2/pt
Publication of BR112015022747A8 publication Critical patent/BR112015022747A8/pt
Publication of BR112015022747B1 publication Critical patent/BR112015022747B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/22—Materials or treatment for tissue regeneration for reconstruction of hollow organs, e.g. bladder, esophagus, urether, uterus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Materials For Medical Uses (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

resumo “materiais de prevenção de obstrução gastrointestinal” materiais e métodos para a prevenção da obstrução gastrointestinal são fornecidos. um peptídeo que compreende entre cerca de 7 aminoácidos e cerca de 32 aminoácidos de uma solução pode ser introduzida num local alvo. o peptídeo pode sofrer auto-organização em condições fisiológicas e / ou na presença de um cátion.
BR112015022747-3A 2013-03-14 2014-03-13 kit para prevenção de estenose e uso de um peptídeo de automontagem BR112015022747B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361785582P 2013-03-14 2013-03-14
US61/785,582 2013-03-14
PCT/IB2014/059748 WO2014141143A1 (en) 2013-03-14 2014-03-13 Materials for gastrointestinal obstruction prevention

Publications (3)

Publication Number Publication Date
BR112015022747A2 true BR112015022747A2 (pt) 2017-07-18
BR112015022747A8 BR112015022747A8 (pt) 2019-12-03
BR112015022747B1 BR112015022747B1 (pt) 2020-10-13

Family

ID=50424678

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015022747-3A BR112015022747B1 (pt) 2013-03-14 2014-03-13 kit para prevenção de estenose e uso de um peptídeo de automontagem

Country Status (10)

Country Link
US (1) US9724448B2 (pt)
EP (1) EP2968693B1 (pt)
JP (2) JP6478927B2 (pt)
KR (1) KR20160003651A (pt)
CN (1) CN105339020B (pt)
AU (1) AU2014229273B2 (pt)
BR (1) BR112015022747B1 (pt)
CA (1) CA2905182A1 (pt)
HK (1) HK1220413A1 (pt)
WO (1) WO2014141143A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010041636A1 (ja) 2008-10-06 2010-04-15 株式会社スリー・ディー・マトリックス 組織閉塞剤
EP3466964A1 (en) 2012-07-06 2019-04-10 3-D Matrix Ltd. Fill-finish process for peptide solutions
WO2015138514A1 (en) * 2014-03-10 2015-09-17 3-D Matrix, Ltd. Self-assembling peptide compositions
WO2015136370A2 (en) 2014-03-10 2015-09-17 3-D Matrix, Ltd. Sterilization and filtration of peptide compositions
US10245299B2 (en) 2014-03-10 2019-04-02 3-D Matrix, Ltd. Autoassembling peptides for the treatment of pulmonary bulla
US10814038B2 (en) 2016-01-06 2020-10-27 3-D Matrix, Ltd. Combination compositions
WO2018005427A1 (en) * 2016-06-27 2018-01-04 3-D Matrix, Ltd. Self-assembling peptide matrix for the prevention of esophageal stricture after endoscopic dissection
JP7012950B2 (ja) * 2016-11-17 2022-01-31 地方独立行政法人東京都立産業技術研究センター 生体組織孔閉鎖用、潰瘍保護用及び血管塞栓療術用ゾル
JP7442196B2 (ja) 2018-07-03 2024-03-04 株式会社スリー・ディー・マトリックス イオン性自己組織化ペプチド
US20210220429A1 (en) * 2018-10-05 2021-07-22 Kurume University Pharmaceutical composition for treating or preventing ulcer or fistula in intestinal tract
CN115397454A (zh) 2020-03-31 2022-11-25 立美基股份有限公司 通过辐照对自组装肽进行灭菌
JP2024506048A (ja) * 2021-02-10 2024-02-08 株式会社スリー・ディー・マトリックス 特異的な自己組織化ペプチドｒａｄａ１６を含む、炎症性腸疾患などの下部消化管疾患を治療又は予防するための医薬組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0500643D0 (en) * 2005-01-13 2005-02-23 Renovo Ltd Medicaments
US9162005B2 (en) * 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
ES2709125T3 (es) * 2006-09-26 2019-04-15 Massachusetts Inst Technology Péptidos autoensamblantes modificados
US20110002880A1 (en) * 2007-12-05 2011-01-06 3-D Matrix, Ltd. Material For Wound Healing and Skin Reconstruction
WO2010041636A1 (ja) 2008-10-06 2010-04-15 株式会社スリー・ディー・マトリックス 組織閉塞剤

Also Published As

Publication number Publication date
AU2014229273B2 (en) 2016-12-01
WO2014141143A1 (en) 2014-09-18
AU2014229273A1 (en) 2015-10-08
BR112015022747B1 (pt) 2020-10-13
CN105339020A (zh) 2016-02-17
CN105339020B (zh) 2020-06-16
CA2905182A1 (en) 2014-09-18
HK1220413A1 (zh) 2017-05-05
US20160000966A1 (en) 2016-01-07
JP6478927B2 (ja) 2019-03-06
JP2018115208A (ja) 2018-07-26
KR20160003651A (ko) 2016-01-11
US9724448B2 (en) 2017-08-08
BR112015022747A8 (pt) 2019-12-03
EP2968693B1 (en) 2022-06-01
EP2968693A1 (en) 2016-01-20
JP2016515113A (ja) 2016-05-26

Similar Documents

Publication Publication Date Title
BR112015022747A2 (pt) materiais de prevenção de obstrução gastrointestinal
CY1123821T1 (el) Συνθεσεις και μεθοδοι για τη θεραπεια της δυσλειτουργιας του μεϊβομιανου αδενα
PH12017501481A1 (en) Bicyclic heterocycles as fgfr inhibitors
BR112015028482A2 (pt) implante cirúrgico que compreende uma camada que tem aberturas
CL2016002235A1 (es) Composiciones útiles en el tratamiento de deficiencia de ornitina-transcarbamilasa (otc)
DK3331864T3 (da) 1,3,4-Oxadiazolderivat-forbindelser som histon-deacetylase-6-hæmmer, og den farmaceutiske sammensætning omfattende disse
BR112015023207A2 (pt) uso de c1-inh no tratamento de desordens associadas à deficiência de inibidor de c1 esterase
BR112015026307A2 (pt) heterociclo bicíclicos como inibidores de fgfr
BR112015020466A2 (pt) inibidores de cdc7
BR112017007144A2 (pt) ácido valproico ou um sal farmaceuticamente aceitável do mesmo, composto, composição farmacêutica, e, composto ou composição para uso, uso, método ou composição.
CL2015001279A1 (es) Compuestos derivados de piridina, inhibidores del transportador de uratos urat 1; composicion farmaceutica que los comprende; uso para el tratamiento o prevencion de enfermedades tales como gota, hiperuricemia, hipertensión, enfermedades renales, entre otras.
BR112015020139A2 (pt) compostos terapêuticos e usos dos mesmos
BR112015030203A2 (pt) moléculas pequenas inibidores da fibrose
BR112014031627A2 (pt) superfícies nanotexturizadas antineblina e artigos contendo os mesmos
ECSP13012913A (es) Anticuerpos monoclonales frente al inhibidor de la ruta del factor tisular (tfpi)
MX2016016832A (es) Materiales y metodos para llenar cavidades oseas.
UY35344A (es) Oestra-1,3,5(10),16-tetraeno-3-carboxamidas
AR120721A2 (es) Péptidos y composiciones para el tratamiento de daño articular
DK3250711T3 (da) Fremgangsmåde og produkt til at forhindre falske positiver i fremgangsmåder anvendende ddntp'er
CN106687453A8 (zh) 作为溴结构域抑制剂的四氢喹啉衍生物
BR112017006969A2 (pt) peptídeo derivado de hsp70, composição farmacêutica para o tratamento ou a prevenção de câncer usando o mesmo, indutor de imunidade e método de produção de célula apresentadora de antígeno
BR112017001971A2 (pt) ?métodos e composições para diagnosticar e tratar distúrbios inflamatórios intestinais?
CO2017001899A2 (es) Tratamiento del cáncer con el inhibidor de la alfa-amilasa en los animales de compañía
EA201792121A1 (ru) Фармацевтические солевые формы ингибитора семикарбазидчувствительной аминоксидазы (ssao)
BR112018077219A2 (pt) matriz de peptídeo de automontagem para a prevenção de estenose esofágica após dissecção endoscópica

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/03/2014, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 8A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2662 DE 11-01-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.